APO Group - Africa Newsroom / Press release | AstraZeneca to partner with UNICEF to help prevent non-communicable diseases among five million young people worldwide
COVID-19: Difficult trade-offs in AstraZeneca vaccine development | Science| In-depth reporting on science and technology | DW | 28.10.2020
A leading coronavirus vaccine trial is on hold: scientists react
Halting the Oxford vaccine trial doesn't mean it's not safe – it shows they're following the right process
AstraZeneca Has Resumed Its U.K. COVID-19 Vaccine Trial | Time
Coronavirus vaccine: Europe's Inclusive Vaccines Alliance strikes giant agreement with AstraZeneca | Euronews
AstraZeneca Covid-19 vaccine study is put on hold
AstraZeneca accelerates drug discovery thanks to PELE technology | BSC-CNS
AstraZeneca partners its way to a genomic bounty | Science | AAAS
News in brief | Nature Reviews Drug Discovery
Why AstraZeneca and others racing to make a COVID-19 vaccine should be more open about the process
AstraZeneca COVID-19 vaccine shows average efficiency of 70% - CGTN
Israel - AstraZeneca
AstraZeneca's COVID-19 vaccine shows midphase promise in seniors | FierceBiotech
Investments in health systems
AstraZeneca aims to go carbon free by 2025—and it'll spend $1B to do it | FiercePharma
Egypt - AstraZeneca
AstraZeneca puts Covid-19 vaccine trial on hold over safety concern: Report - world news - Hindustan Times
Greening Australia to deliver one of Australia's largest-ever restoration projects - Greening Australia - Greening Australia
Oxford and AstraZeneca to resume Covid vaccine trial, Health News, ET HealthWorld
The COVID vaccine challenges that lie ahead
AstraZeneca accelerates drug discovery thanks to PELE technology | BSC-CNS
COVID-19 clinical MDT experience sharing webcast
AstraZeneca Faces Difficult Questions About Its Vaccine After Admitting Mistake - The New York Times
Daily briefing: 'Serendipity' boosted Oxford–AstraZeneca vaccine's efficacy
AstraZeneca-Oxford Coronavirus Vaccine Trials Paused After Unexpected Illness In Volunteer
